Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | ATP2A2 | P16615 | 1/20 | 0.35 |
| ▸ | ATP2A3 | Q93084 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | TYR | P14679 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18261198 | 0.84 | CYP1A2 (0.33) | ALDH1A1SMN1; SMN2KDM4ECYP1A2MAPT | |
| SCHEMBL7132801 | 0.67 | ALDH1A1 (0.53) | ALDH1A1SMN1; SMN2KDM4ECYP1A2MAPT | |
| SCHEMBL16411257 | 0.65 | ALDH1A1 (0.39) | ALDH1A1SMN1; SMN2KDM4ECYP1A2MAPT | |
| SCHEMBL18261188 | 0.65 | PGR (0.31) | — | |
| SCHEMBL31437683 | 0.62 | EEF2K (0.42) | ALDH1A1SMN1; SMN2KDM4ECYP1A2MAPT | |
| SCHEMBL19049547 | 0.61 | — | — | |
| SCHEMBL19675543 | 0.60 | ALDH1A1 (0.35) | ALDH1A1SMN1; SMN2KDM4ECYP1A2MAPT | |
| SCHEMBL13903365 | 0.60 | ALOX15 (0.42) | ALDH1A1SMN1; SMN2KDM4ECYP1A2MAPT | |
| SCHEMBL19675726 | 0.59 | ALDH1A1 (0.33) | ALDH1A1SMN1; SMN2KDM4ECYP1A2MAPT | |
| SCHEMBL24910469 | 0.58 | SMN1; SMN2 (0.45) | ALDH1A1SMN1; SMN2KDM4ECYP1A2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180079841-A1 | METALLOCENE SUPPORTED CATALYST AND METHOD FOR PREPARING POLYOLEFIN USING THE SAME | LG CHEM, LTD. (KR) | 2018-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180079841-A1 | METALLOCENE SUPPORTED CATALYST AND METHOD FOR PREPARING POLYOLEFIN USING THE SAME | PCBP1, SOD1, PCLAF | ALDH1A1 2034/4885SMN1; SMN2 1179/4885KDM4E 2644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.